REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Venn Biosciences Sdn. Bhd. (Malaysia)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Venn Biosciences Sdn. Bhd. Profile Updated: November 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Venn Biosciences Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Petaling Jaya. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on November 03, 2017. The company’s latest financial report indicates a net sales revenue drop of 48.82% in 2023. Its’ total assets recorded a negative growth of 98.04%.

Legal Address
802 8Th Floor, Block C Kelana Square,, 17 Jalan Ss7/26
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Venn Biosciences Sdn. Bhd. report to view the information.

Website: http://www.intervenn.com

Basic Information
Financial Auditors:
Purchase the Venn Biosciences Sdn. Bhd. report to view the information.
Incorporation Date:
November 03, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Venn Biosciences Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-48.82%▼
Total Operating Revenue
-48.82%▼
Operating Profit
N/A
Net Profit/Loss for the Period
N/A
Total Assets
-98.04%▼
Total Equity
N/A
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
78.22%▲
Quick Ratio
-0.19%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo